Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Stage III NSCLC”

260 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 260 results

Testing effectiveness (Phase 2)Study completedNCT03102242
What this trial is testing

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Alliance Foundation Trials, LLC. 64
Not applicableStudy completedNCT03995875
What this trial is testing

Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 529
Testing effectiveness (Phase 2)Study completedNCT01652820
What this trial is testing

Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer

Who this might be right for
Non Small-cell Lung Cancer
Spanish Lung Cancer Group 140
Testing effectiveness (Phase 2)Study completedNCT01733589
What this trial is testing

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Who this might be right for
Stage III Non-small-Cell Lung Cancer
Zhejiang Cancer Hospital 73
Testing effectiveness (Phase 2)Study completedNCT02733250
What this trial is testing

Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 10
Large-scale testing (Phase 3)Study completedNCT04513925
What this trial is testing

Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche 829
Testing effectiveness (Phase 2)UnknownNCT04952168
What this trial is testing

Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

Who this might be right for
NSCLC, Stage III
Yuan Chen 26
Testing effectiveness (Phase 2)Ended earlyNCT00958321
What this trial is testing

Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Who this might be right for
Lung CancerMetastatic Cancer
Cancer Trials Ireland 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03225664
What this trial is testing

Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03965689
What this trial is testing

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

Who this might be right for
Metastatic Lung Non-Small Cell Squamous CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8+5 more
National Cancer Institute (NCI)
Not applicableUnknownNCT05641870
What this trial is testing

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

Who this might be right for
Lung CancerStage III Lung CancerUnresectable Lung Carcinoma
Parc de Salut Mar 80
Testing effectiveness (Phase 2)UnknownNCT04111913
What this trial is testing

Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Unresectable Stage III Non-small Cell Lung Cancer
Nanfang Hospital, Southern Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06667908
What this trial is testing

JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Johnson & Johnson Enterprise Innovation Inc. 130
Testing effectiveness (Phase 2)Study completedNCT00268970
What this trial is testing

Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Agennix 40
Large-scale testing (Phase 3)Ended earlyNCT03745222
What this trial is testing

Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Celgene 1
Not applicableStudy completedNCT02458651
What this trial is testing

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

Who this might be right for
Non-Small Cell Lung Cancer, Lung Cancer, Cancer
Hoffmann-La Roche 1,378
Large-scale testing (Phase 3)Ended earlyNCT02049151
What this trial is testing

Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
EMD Serono 35
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT04667312
What this trial is testing

Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom

Who this might be right for
Non-Small Cell Lung Cancer NSCLC
AstraZeneca 115
Next Page
27